Its two major shareholders are Boustead Holdings and Lembaga Tabung Angkatan Tentera (LTAT).

Pharmaniaga's expertise extends beyond manufacturing, encompassing logistics and distribution, as well as dynamic sales and marketing strategies that ensure their products reach those in need nationwide.

[citation needed] With five manufacturing plants, including Indonesia plant, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables.

Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory, amongst others.

MPI is a public listed company on the Indonesia Stock Exchange with 35 branches nationwide.